Evidence map›Paper›PMID 33037213›Full record

ArticleNature communications2020

Accommodating individual travel history and unsampled diversity in Bayesian phylogeographic inference of SARS-CoV-2.

Philippe Lemey, Samuel L Hong, Verity Hill, Guy Baele, Chiara Poletto, Vittoria Colizza, Áine O'Toole, John T McCrone, Kristian G Andersen, Michael Worobey and 3 more

Abstract read
In one paragraph

Article in Nature communications, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 119 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
119citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

119 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Estimating epidemic dynamics with genomic and time series data.Journal of the Royal Society, Interface · 2025
    Article
  17. Article
  18. Article
  19. Article
  20. Article

59 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Philippe LemeyDepartment of Microbiology, Immunology and Transplantation, Rega Institute, KU Leuven, Laboratory of Clinical and Evolutionary Virology, Leuven, Belgium. philippe.lemey@kuleuven.be.ORCID http://orcid.org/0000-0003-2826-5353
Samuel L HongDepartment of Microbiology, Immunology and Transplantation, Rega Institute, KU Leuven, Laboratory of Clinical and Evolutionary Virology, Leuven, Belgium.ORCID http://orcid.org/0000-0001-6354-4943
Verity HillInstitute of Evolutionary Biology, University of Edinburgh, Edinburgh, EH9 3FL, UK.ORCID http://orcid.org/0000-0002-3509-8146
Guy BaeleDepartment of Microbiology, Immunology and Transplantation, Rega Institute, KU Leuven, Laboratory of Clinical and Evolutionary Virology, Leuven, Belgium.
Chiara PolettoINSERM, Sorbonne Université, Institut Pierre Louis d'Epidémiologie et de Santé Publique IPLESP, F75012, Paris, France.
Vittoria ColizzaINSERM, Sorbonne Université, Institut Pierre Louis d'Epidémiologie et de Santé Publique IPLESP, F75012, Paris, France.ORCID http://orcid.org/0000-0002-2113-2374
Áine O'TooleInstitute of Evolutionary Biology, University of Edinburgh, Edinburgh, EH9 3FL, UK.ORCID http://orcid.org/0000-0001-8083-474X
John T McCroneInstitute of Evolutionary Biology, University of Edinburgh, Edinburgh, EH9 3FL, UK.
Kristian G AndersenDepartment of Immunology and Microbiology, Scripps Research, La Jolla, CA, 92037, USA.
Michael WorobeyDepartment of Ecology and Evolutionary Biology, University of Arizona, Tucson, AZ, 85721, USA.
Martha I NelsonDivision of International Epidemiology and Population Studies, Fogarty International Center, National Institutes of Health, Bethesda, MD, 20892, USA.
Andrew RambautInstitute of Evolutionary Biology, University of Edinburgh, Edinburgh, EH9 3FL, UK.ORCID http://orcid.org/0000-0003-4337-3707
Marc A SuchardDepartment of Biomathematics, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, 90095, USA. msuchard@ucla.edu.ORCID http://orcid.org/0000-0001-9818-479X

Funding

Technology CoreU19AI135995 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI Kristian Graugaard Andersen · 2018 to 2026
$32.0M
West African Emerging Infectious Disease Research Center (WA-EIDRC)U01AI151812 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI ANDERSEN, KRISTIAN GRAUGAARD, GARRY, ROBERT F · 2020 to 2024
$13.2M
NIAID NIH HHS U01 AI151812NIAID NIH HHS U19 AI135995
6 · The paper itself

Abstract

Spatiotemporal bias in genome sampling can severely confound discrete trait phylogeographic inference. This has impeded our ability to accurately track the spread of SARS-CoV-2, the virus responsible for the COVID-19 pandemic, despite the availability of unprecedented numbers of SARS-CoV-2 genomes. Here, we present an approach to integrate individual travel history data in Bayesian phylogeographic inference and apply it to the early spread of SARS-CoV-2. We demonstrate that including travel history data yields i) more realistic hypotheses of virus spread and ii) higher posterior predictive accuracy compared to including only sampling location. We further explore methods to ameliorate the impact of sampling bias by augmenting the phylogeographic analysis with lineages from undersampled locations. Our reconstructions reinforce specific transmission hypotheses suggested by the inclusion of travel history data, but also suggest alternative routes of virus migration that are plausible within the epidemiological context but are not apparent with current sampling efforts.

Indexed as

TravelBayes TheoremBetacoronavirusCoronavirus InfectionsCOVID-19Genome, ViralHumansPandemicsPhylogenyPhylogeographyPneumonia, ViralSARS-CoV-2

Identifiers

PMID33037213
PMCPMC7547076

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.